These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6272994)

  • 1. Cefotaxime: clinical and bacteriologic evaluation.
    Saroglou G; Paniara-Volika O; Sima A; Koltsida K; Rokas S; Kontomichalou P
    Clin Ther; 1981; 4(3):201-11. PubMed ID: 6272994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M; Dickgiesser N; Müller S; Wundt W
    Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
    Harper PB
    Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of clinical isolates to cephalexin, cefazolin and cefotaxime.
    Gupta BL; Tahlan A; Dogra V; Rattan A; Bhujwala RA; Shriniwas
    Indian Pediatr; 1989 May; 26(5):466-71. PubMed ID: 2599615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activity of new cephalosporins against polyresistant bacterial strains].
    De Toffoli A; Fantin B
    Minerva Med; 1983 Mar; 74(9-10):427-31. PubMed ID: 6300736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the minimum inhibiting concentration of a new cephalosporin (HR 756): comparative data with other beta-lactamic antibiotics].
    Mascellino MT; Prignano G; Iegri F; Delia S
    Boll Ist Sieroter Milan; 1981 May; 60(2):102-9. PubMed ID: 6272823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of six beta-lactam antibiotics against non-beta-lactamase producing and producing enterobacteria and antibiotic resistance transfer.
    Scioli C; Esposito S; Martinelli R
    Boll Ist Sieroter Milan; 1984 Sep; 63(4):338-47. PubMed ID: 6335045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of susceptibility of bacteria isolated from clinical material to cefuroxime, ceftazidime and cefotaxime].
    Giedrys-Kalemba S; Bilska I
    Med Dosw Mikrobiol; 1993; 45(2):173-6. PubMed ID: 8309292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of HR-756, cefoxitin and cefuroxine against multiply antibiotic-resistant strains of Enterobacteriaceae and Pseudomonas aeruginosa.
    Legakis NJ; Kafetzis DA; Papadatos CJ; Papavassiliou JT
    Chemotherapy; 1980; 26(5):334-43. PubMed ID: 6248301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefoxitin sensitivity as a marker for inducible beta-lactamases.
    Moritz VA; Carson PB
    J Med Microbiol; 1986 May; 21(3):203-7. PubMed ID: 3486293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
    Concia E; Marone P; Verani D; Marino P
    Boll Ist Sieroter Milan; 1982; 61(4):300-8. PubMed ID: 6100233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of amoxycillin-clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin.
    Docobo-Pérez F; Fernández-Cuenca F; Pachón-Ibáñez ME; Pascual A; Pichardo C; Martínez-Martínez L; Pachón J
    Clin Microbiol Infect; 2008 Jun; 14(6):582-7. PubMed ID: 18294246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiologic and clinical studies with cefuroxime.
    Graber H; Arr M; Magyar T; Ludwig E
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):399-403. PubMed ID: 6629544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefuroxime resistance in Klebsiella pneumoniae. Susceptibility to cefotaxime and ceftazidime despite production of ESBLs.
    Schumacher H; Skibsted U; Hansen DS; Scheibel J
    APMIS; 1997 Sep; 105(9):708-16. PubMed ID: 9350215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
    J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.
    Bartmann K; Tarbuc R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):202-10. PubMed ID: 6324518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative evaluation of the antibacterial activity of cefotaxime and cephalotin by using an automated antimicrobial susceptibility determination system].
    Concia E; Marone P; Dos Santos C; Bono L
    Quad Sclavo Diagn; 1982 Jun; 18(2):223-32. PubMed ID: 6300953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefotaxime: microbiology, pharmacology, and clinical use.
    Dudley MN; Barriere SL
    Clin Pharm; 1982; 1(2):114-24. PubMed ID: 6309465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.